ID

23052

Descripción

Safety and Effectiveness of D-Serine in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00322023

Link

https://clinicaltrials.gov/show/NCT00322023

Palabras clave

Versiones (1)
  1. 21/6/17 21/6/17 -
Subido en

21 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00322023

Inglés

Eligibility Schizophrenia NCT00322023

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
structured clinical interview for dsm-iii-r diagnosis of schizophrenia or schizoaffective disorder
Descripción

Schizophrenia | Schizoaffective Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036337
panss 3 factor negative symptom inclusion score greater than 20 prior to study entry
Descripción

Positive and negative syndrome scale Factor Analysis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0451383
UMLS CUI [1,2]
C0085801
panss total score between 60 and 110
Descripción

Positive and negative syndrome scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451383
simpson-angus scale total score of 12 or less
Descripción

Rating scale Parkinsonism

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0681889
UMLS CUI [1,2]
C0242422
calgary depression inventory total score of 10 and suicide score less than 2
Descripción

Depression score | Suicide score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3483981
UMLS CUI [2]
C0560334
no change in clinical global impressions (cgi) scale score prior to study entry
Descripción

Clinical Global Impression Questionnaire unchanged

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3639708
UMLS CUI [1,2]
C0442739
chlorpromazine (cpz) equivalent of 1500 or less
Descripción

Chlorpromazine equivalent Dosage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008286
UMLS CUI [1,2]
C3242703
UMLS CUI [1,3]
C0178602
willing to use an effective form of birth control throughout the study if sexually active
Descripción

Sexually active Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0241028
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
high extrapyramidal symptom (eps) levels
Descripción

Extrapyramidal symptoms High

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0234133
UMLS CUI [1,2]
C0205250
began, discontinued, or adjusted psychotropic medication within 2 weeks of study entry
Descripción

Psychotropic Drugs Started | Psychotropic Drugs Discontinued | Psychotropic Drugs Adjusted

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C1272689
UMLS CUI [2,1]
C0033978
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C0033978
UMLS CUI [3,2]
C0456081
taking investigational medication within 2 weeks of study entry
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
contraindication to study medication
Descripción

Medical contraindication Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
serious or unstable medical illness
Descripción

Illness Serious | Illness Unstable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0443343
pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
alcohol or drug abuse within 6 months of study entry
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
diagnosed with neurodegenerative disease or a seizure disorder
Descripción

Neurodegenerative Disorders | Epilepsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0524851
UMLS CUI [2]
C0014544
history of a kidney impairment
Descripción

Renal Insufficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
currently taking clozapine
Descripción

Clozapine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009079
currently taking more than two antipsychotic medications
Descripción

Antipsychotic Agents Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040615
UMLS CUI [1,2]
C1265611
currently taking stimulants or cholinesterase inhibitors
Descripción

Stimulant | Cholinesterase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304402
UMLS CUI [2]
C0008425
Volver a la parte superior de la página

Similar models

Eligibility Schizophrenia NCT00322023

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia | Schizoaffective Disorder
Item
structured clinical interview for dsm-iii-r diagnosis of schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Positive and negative syndrome scale Factor Analysis
Item
panss 3 factor negative symptom inclusion score greater than 20 prior to study entry
boolean
C0451383 (UMLS CUI [1,1])
C0085801 (UMLS CUI [1,2])
Positive and negative syndrome scale
Item
panss total score between 60 and 110
boolean
C0451383 (UMLS CUI [1])
Rating scale Parkinsonism
Item
simpson-angus scale total score of 12 or less
boolean
C0681889 (UMLS CUI [1,1])
C0242422 (UMLS CUI [1,2])
Depression score | Suicide score
Item
calgary depression inventory total score of 10 and suicide score less than 2
boolean
C3483981 (UMLS CUI [1])
C0560334 (UMLS CUI [2])
Clinical Global Impression Questionnaire unchanged
Item
no change in clinical global impressions (cgi) scale score prior to study entry
boolean
C3639708 (UMLS CUI [1,1])
C0442739 (UMLS CUI [1,2])
Chlorpromazine equivalent Dosage
Item
chlorpromazine (cpz) equivalent of 1500 or less
boolean
C0008286 (UMLS CUI [1,1])
C3242703 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Sexually active Contraceptive methods
Item
willing to use an effective form of birth control throughout the study if sexually active
boolean
C0241028 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Extrapyramidal symptoms High
Item
high extrapyramidal symptom (eps) levels
boolean
C0234133 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
Psychotropic Drugs Started | Psychotropic Drugs Discontinued | Psychotropic Drugs Adjusted
Item
began, discontinued, or adjusted psychotropic medication within 2 weeks of study entry
boolean
C0033978 (UMLS CUI [1,1])
C1272689 (UMLS CUI [1,2])
C0033978 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0033978 (UMLS CUI [3,1])
C0456081 (UMLS CUI [3,2])
Investigational New Drugs
Item
taking investigational medication within 2 weeks of study entry
boolean
C0013230 (UMLS CUI [1])
Medical contraindication Investigational New Drugs
Item
contraindication to study medication
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Illness Serious | Illness Unstable
Item
serious or unstable medical illness
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Substance Use Disorders
Item
alcohol or drug abuse within 6 months of study entry
boolean
C0038586 (UMLS CUI [1])
Neurodegenerative Disorders | Epilepsy
Item
diagnosed with neurodegenerative disease or a seizure disorder
boolean
C0524851 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Renal Insufficiency
Item
history of a kidney impairment
boolean
C1565489 (UMLS CUI [1])
Clozapine
Item
currently taking clozapine
boolean
C0009079 (UMLS CUI [1])
Antipsychotic Agents Quantity
Item
currently taking more than two antipsychotic medications
boolean
C0040615 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Stimulant | Cholinesterase Inhibitors
Item
currently taking stimulants or cholinesterase inhibitors
boolean
C0304402 (UMLS CUI [1])
C0008425 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial